June 25, 2025 (Florianópolis, SC, Brazil) Symbiomics, a biotechnology company that develops high-performance biological products for agriculture, today announced the completion of its Series A funding round to scale its operations, accelerate the development of novel products, and expand its commercial partnerships. The round is led by Corteva Agriscience through its investment platform, Corteva Catalyst, launched in mid-2024. In addition to the multinational, the Series A round includes investments from Arar Capital, Cazanga, MOV Investimentos, and The Yield Lab Latam.
The Brazilian company is the first to receive an investment from Corteva Catalyst in the country. “Corteva’s investment represents an important recognition of Symbiomics as a company committed to developing innovative technologies for agribusiness,” said Rafael de Souza, co-founder and CEO of the company. “More than that, it is a significant step toward a more sustainable agriculture. The Series A funding will allow us to accelerate our developments and strengthen partnerships across the sector,” he added.
Read more
Originally published by Symbiomics in June 2025.